Palisade Bio Inc. (PALI) NASDAQ
$6.07 (0.31) (-4.86%)
Market Cap: $5.98M
As of 05/16/24 10:46 AM EDT. Market open.
Palisade Bio Inc. (PALI)
NASDAQ
$6.07
(0.31) (-4.86%)
Market Cap: $5.98M
As of 05/16/24 10:46 AM EDT. Market open.
Add to Portfolio
... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Kenneth Carter
Address
20271 Goldenrod Ln Ste 2024, Maryland, Germantown, 20876.
PRICE CHART FOR PALISADE BIO INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$6.05
Previous Close
$6.38
Days Range
$6.14 - $6.61
52 week range
$3.82 - $36.60
Volume
10,715
Avg. Volume (30 days)
1,893,822
Market Cap
$5.98M
Dividend Yield
-
P/E
(0.54)
Shares Outstanding
937,562
Open
$6.05
Previous Close
$6.38
Days Range
$6.14 - $6.61
52 week range
$3.82 - $36.60
Volume
10,715
Avg. Volume (30 days)
1,893,822
Market Cap
$5.98M
Dividend Yield
-
P/E
(0.54)
Shares Outstanding
937,562
FINANCIAL STATEMENTS FOR PALISADE BIO INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR PALISADE BIO INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Jones Mitchell Lawrence | CEO, CFO, Director | May 06, 2024 | Option Exercise | $8.46 | 137 | 1,159 | 833 | May 08, 2024, 06:37 PM |
| Finley John David | CEO, CFO, Director | May 06, 2024 | Option Exercise | $8.46 | 128 | 1,083 | 6,771 | May 08, 2024, 06:36 PM |
| Jones Mitchell Lawrence | Chief Medical Officer | Feb 06, 2024 | Option Exercise | $0.44 | 2,153 | 939 | 7,662 | Feb 08, 2024, 04:38 PM |
| Finley John David | CEO, CFO, Director | Feb 06, 2024 | Buy | $0.47 | 10,000 | 4,692 | 84,649 | Feb 07, 2024, 08:30 AM |
| Finley John David | CEO, CFO, Director | Jan 31, 2024 | Buy | $0.56 | 10,000 | 5,590 | 74,649 | Feb 01, 2024, 08:30 AM |
| Williams Donald Allen | Director | Jan 31, 2024 | Buy | $0.61 | 10,000 | 6,050 | 30,000 | Feb 01, 2024, 08:30 AM |
| Finley John David | CEO, CFO, Director | Nov 20, 2023 | Option Exercise | $0.51 | 10,000 | 5,100 | 57,781 | Nov 24, 2023, 04:00 PM |
| Jones Mitchell Lawrence | Chief Medical Officer | Nov 07, 2023 | Option Exercise | $0.54 | 1,630 | 878 | 2,926 | Nov 08, 2023, 05:01 PM |
| Finley John David | CEO, CFO, Director | Oct 04, 2023 | Option Exercise | $0.55 | 397 | 218 | 44,306 | Oct 05, 2023, 05:46 PM |
| Williams Donald Allen | Director | Sep 27, 2023 | Buy | $0.54 | 20,000 | 10,800 | 20,000 | Sep 29, 2023, 09:25 AM |
| Finley John David | CEO, CFO, Director | Sep 27, 2023 | Buy | $0.54 | 15,000 | 8,088 | 43,394 | Sep 29, 2023, 09:21 AM |
| Trenschel Robert J. | Director | Sep 14, 2023 | Sale | $0.64 | 300 | 192 | 0 | Sep 15, 2023, 05:15 PM |
| Finley John David | CEO, CFO, Director | Sep 13, 2023 | Buy | $0.65 | 15,000 | 9,825 | 28,394 | Sep 14, 2023, 05:00 PM |
| Finley John David | CEO, CFO, Director | Sep 12, 2023 | Option Exercise | $0.65 | 1,792 | 1,174 | 13,394 | Sep 13, 2023, 04:55 PM |
| Finley John David | CEO, CFO, Director | Aug 11, 2023 | Option Exercise | $0.70 | 1,040 | 728 | 9,628 | Aug 14, 2023, 06:33 PM |
| Finley John David | CEO, CFO, Director | Jul 06, 2023 | Option Exercise | $1.76 | 389 | 686 | 7,193 | Jul 06, 2023, 06:27 PM |
| Finley John David | CEO, CFO, Director | Jun 13, 2023 | Option Exercise | $1.54 | 1,050 | 1,619 | 6,273 | Jun 14, 2023, 06:23 PM |
| McRae Robert Curtis | Chief Operating Officer | Apr 03, 2023 | Option Exercise | $2.00 | 270 | 540 | 625 | Apr 05, 2023, 06:52 PM |
| Finley John David | CEO, CFO, Director | Apr 03, 2023 | Option Exercise | $2.01 | 435 | 874 | 3,848 | Apr 05, 2023, 06:49 PM |
| Finley John David | Chief Financial Officer | Sep 01, 2022 | Buy | $0.14 | 19,481 | 2,799 | 148,727 | Sep 02, 2022, 06:21 PM |
| Finley John David | Chief Financial Officer | Aug 23, 2022 | Buy | $0.16 | 7,350 | 1,176 | 129,246 | Aug 25, 2022, 05:10 PM |
| Hallam Thomas | Chief Executive Officer | Aug 16, 2022 | Buy | $0.25 | 40,000 | 10,000 | 57,592 | Aug 18, 2022, 09:06 PM |
| Finley John David | Chief Financial Officer | Aug 16, 2022 | Buy | $0.25 | 100,000 | 25,000 | 121,896 | Aug 18, 2022, 09:04 PM |
| Dawson Michael John | Chief Medical Officer | Mar 29, 2022 | Buy | $1.14 | 15,000 | 17,093 | 15,000 | Mar 31, 2022, 08:31 AM |
| Hallam Thomas | Chief Executive Officer | Mar 28, 2022 | Buy | $1.18 | 10,000 | 11,800 | 17,592 | Mar 29, 2022, 08:37 AM |
| Finley John David | Chief Financial Officer | Mar 24, 2022 | Buy | $1.09 | 7,500 | 8,174 | 21,896 | Mar 25, 2022, 08:01 AM |
| Finley John David | Chief Financial Officer | Sep 21, 2021 | Buy | $2.44 | 2,000 | 4,880 | 14,396 | Sep 22, 2021, 07:36 PM |
| Hallam Thomas | Chief Executive Officer | Sep 21, 2021 | Buy | $2.49 | 6,000 | 14,940 | 7,592 | Sep 22, 2021, 07:35 PM |
| Trenschel Robert J. | Director | Sep 09, 2021 | Buy | $2.89 | 3,400 | 9,826 | 12,857 | Sep 13, 2021, 06:40 PM |
| Trenschel Robert J. | Director | Sep 08, 2021 | Buy | $2.75 | 5,000 | 13,750 | 9,457 | Sep 13, 2021, 06:40 PM |
| Trenschel Robert J. | Director | Sep 07, 2021 | Buy | $2.78 | 2,707 | 7,525 | 4,457 | Sep 13, 2021, 06:40 PM |
| Trenschel Robert J. | Director | Aug 31, 2021 | Buy | $2.75 | 1,750 | 4,813 | 1,750 | Sep 13, 2021, 06:40 PM |
| Trenschel Robert J. | Director | Sep 10, 2021 | Buy | $2.98 | 2,142 | 6,383 | 14,999 | Sep 13, 2021, 06:40 PM |
| Finley John David | Chief Financial Officer | Aug 27, 2021 | Buy | $2.65 | 10,000 | 26,468 | 12,396 | Aug 30, 2021, 02:01 PM |
| Daly Richard J | Chief Executive Officer | May 17, 2017 | Buy | $4.00 | 7,500 | 30,000 | 23,312 | May 18, 2017, 01:02 PM |
| LLOYD JONES JONATHAN BRIAN | Chief Financial Officer | Mar 24, 2017 | Buy | $5.50 | 5,455 | 30,003 | 7,859 | Mar 27, 2017, 04:06 PM |
| Daly Richard J | Chief Executive Officer | Feb 24, 2017 | Buy | $3.86 | 2,591 | 10,001 | 15,812 | Feb 27, 2017, 04:30 PM |
| Daly Richard J | Chief Executive Officer | Jan 25, 2017 | Buy | $3.52 | 2,841 | 10,000 | 13,221 | Jan 27, 2017, 04:18 PM |
| Daly Richard J | Chief Executive Officer | Dec 23, 2016 | Buy | $0.31 | 32,259 | 10,000 | 134,939 | Dec 30, 2016, 04:05 PM |
| Daly Richard J | Chief Executive Officer | Nov 25, 2016 | Buy | $0.28 | 35,715 | 10,000 | 102,680 | Nov 28, 2016, 05:36 PM |
| Daly Richard J | Chief Executive Officer | Oct 25, 2016 | Buy | $0.28 | 35,715 | 10,000 | 66,965 | Oct 27, 2016, 04:05 PM |
| LLOYD JONES JONATHAN BRIAN | Chief Financial Officer | Sep 23, 2016 | Buy | $0.32 | 31,250 | 10,000 | 31,250 | Sep 26, 2016, 04:51 PM |
| Daly Richard J | Chief Executive Officer | Sep 23, 2016 | Buy | $0.32 | 31,250 | 10,000 | 31,250 | Sep 26, 2016, 04:50 PM |
| GARR RICHARD | CEO | Jan 27, 2016 | Option Exercise | $0.67 | 6,465 | 4,332 | 1,449,804 | Jan 28, 2016, 04:00 PM |
| GARR RICHARD | CEO | Nov 19, 2015 | Option Exercise | $1.14 | 37,776 | 43,065 | 1,436,467 | Nov 20, 2015, 04:14 PM |
| JOHE KARL | Chief Scientific Officer | Nov 19, 2015 | Option Exercise | $1.14 | 39,178 | 44,663 | 930,373 | Nov 20, 2015, 04:11 PM |
| JOHE KARL | Chief Scientific Officer | Nov 16, 2015 | Sale | $1.09 | 25,000 | 27,250 | 826,304 | Nov 16, 2015, 07:40 PM |
| JOHE KARL | Chief Scientific Officer | Nov 09, 2015 | Sale | $1.18 | 25,000 | 29,500 | 851,304 | Nov 09, 2015, 08:17 PM |
| JOHE KARL | Chief Scientific Officer | Nov 02, 2015 | Sale | $1.17 | 25,000 | 29,355 | 876,304 | Nov 03, 2015, 07:11 PM |
| JOHE KARL | Chief Scientific Officer | Oct 26, 2015 | Sale | $1.13 | 25,000 | 28,190 | 901,304 | Oct 27, 2015, 04:38 PM |
| JOHE KARL | Chief Scientific Officer | Oct 19, 2015 | Sale | $1.23 | 25,000 | 30,690 | 926,304 | Oct 19, 2015, 05:14 PM |
| JOHE KARL | Chief Scientific Officer | Oct 12, 2015 | Sale | $1.31 | 25,000 | 32,725 | 951,304 | Oct 13, 2015, 06:49 PM |
| JOHE KARL | Chief Scientific Officer | Oct 05, 2015 | Sale | $1.26 | 25,000 | 31,460 | 976,304 | Oct 05, 2015, 06:27 PM |
| JOHE KARL | Chief Scientific Officer | Sep 28, 2015 | Sale | $1.64 | 25,000 | 41,000 | 1,001,304 | Sep 28, 2015, 08:45 PM |
| JOHE KARL | Chief Scientific Officer | Sep 21, 2015 | Sale | $1.52 | 25,000 | 38,078 | 1,026,304 | Sep 21, 2015, 09:24 PM |
| GARR RICHARD | CEO | Jul 24, 2015 | Option Exercise | $1.93 | 380,263 | 733,908 | 1,503,074 | Jul 27, 2015, 04:09 PM |
| GARR RICHARD | CEO | Jul 24, 2015 | Option Exercise | $0.50 | 800,000 | 400,000 | 1,883,337 | Jul 27, 2015, 04:09 PM |
| JOHE KARL | Chief Scientific Officer | Jul 22, 2015 | Option Exercise | $1.64 | 621,016 | 1,018,466 | 1,067,931 | Jul 24, 2015, 04:16 PM |
| JOHE KARL | Chief Scientific Officer | Jul 22, 2015 | Option Exercise | $0.50 | 1,200,000 | 600,000 | 1,688,947 | Jul 24, 2015, 04:16 PM |
| OLDAKER WILLIAM CLYDE | Director | May 27, 2015 | Option Exercise | $1.63 | 48,589 | 79,200 | 128,350 | Jun 01, 2015, 04:04 PM |
| OLDAKER WILLIAM CLYDE | Director | May 27, 2015 | Option Exercise | $1.32 | 60,000 | 79,200 | 176,939 | Jun 01, 2015, 04:04 PM |
| OGILVIE SCOTT VARDE | Director | May 22, 2015 | Option Exercise | $1.64 | 48,293 | 79,201 | 32,544 | May 29, 2015, 04:41 PM |
| OGILVIE SCOTT VARDE | Director | May 22, 2015 | Option Exercise | $1.32 | 60,000 | 79,200 | 80,837 | May 29, 2015, 04:41 PM |
| JOHE KARL | Chief Scientific Officer | Sep 02, 2014 | Sale | $4.09 | 6,000 | 24,540 | 495,747 | Sep 03, 2014, 06:54 PM |
| JOHE KARL | Chief Scientific Officer | Aug 01, 2014 | Sale | $2.78 | 6,000 | 16,680 | 484,247 | Aug 04, 2014, 06:18 PM |
| JOHE KARL | Chief Scientific Officer | Jul 01, 2014 | Sale | $4.17 | 6,000 | 25,020 | 490,247 | Jul 01, 2014, 04:33 PM |
| JOHE KARL | Chief Scientific Officer | Jun 02, 2014 | Sale | $4.25 | 6,000 | 25,500 | 496,247 | Jun 02, 2014, 04:01 PM |
| OLDAKER WILLIAM CLYDE | Director | May 05, 2014 | Buy | $3.50 | 985 | 3,448 | 985 | May 07, 2014, 05:30 PM |
| OLDAKER WILLIAM CLYDE | Director | May 05, 2014 | Buy | $3.50 | 14,250 | 49,874 | 116,939 | May 07, 2014, 05:30 PM |
| JOHE KARL | Chief Scientific Officer | May 01, 2014 | Sale | $3.54 | 18,000 | 63,765 | 502,247 | May 05, 2014, 04:00 PM |
| GARR RICHARD | CEO | Apr 22, 2014 | Sale | $4.25 | 7,000 | 29,750 | 240,000 | Apr 23, 2014, 04:03 PM |
| OLDAKER WILLIAM CLYDE | Director | Apr 09, 2014 | Option Exercise | $4.66 | 9,871 | 45,999 | 99,429 | Apr 11, 2014, 04:17 PM |
| OLDAKER WILLIAM CLYDE | Director | Apr 09, 2014 | Option Exercise | $3.30 | 20,000 | 66,000 | 109,300 | Apr 11, 2014, 04:17 PM |
| OGILVIE SCOTT VARDE | Director | Apr 09, 2014 | Option Exercise | $4.66 | 14,163 | 66,000 | 20,837 | Apr 11, 2014, 04:12 PM |
| OGILVIE SCOTT VARDE | Director | Apr 09, 2014 | Option Exercise | $3.30 | 20,000 | 66,000 | 35,000 | Apr 11, 2014, 04:12 PM |
| JOHE KARL | Chief Scientific Officer | Apr 01, 2014 | Sale | $4.11 | 6,000 | 24,638 | 525,747 | Apr 02, 2014, 07:10 PM |
| JOHE KARL | Chief Scientific Officer | Mar 20, 2014 | Sale | $4.04 | 6,000 | 24,249 | 531,747 | Mar 21, 2014, 04:14 PM |
| GARR RICHARD | CEO | Jan 24, 2014 | Option Exercise | $3.04 | 205,990 | 626,210 | 1,389,538 | Feb 13, 2014, 04:04 PM |
| GARR RICHARD | CEO | Jan 24, 2014 | Option Exercise | $0.50 | 400,000 | 200,000 | 1,455,327 | Feb 13, 2014, 04:04 PM |
| GARR RICHARD | CEO | Jan 24, 2014 | Option Exercise | $3.04 | 65,789 | 199,999 | 1,389,538 | Jan 27, 2014, 04:03 PM |
| GARR RICHARD | CEO | Jan 24, 2014 | Option Exercise | $0.50 | 400,000 | 200,000 | 1,455,327 | Jan 27, 2014, 04:03 PM |
| JOHE KARL | Chief Scientific Officer | Oct 21, 2013 | Sale | $2.35 | 10,000 | 23,458 | 684,994 | Nov 07, 2013, 04:02 PM |
| JOHE KARL | Chief Scientific Officer | Oct 18, 2013 | Sale | $2.44 | 10,000 | 24,446 | 694,994 | Oct 21, 2013, 01:28 PM |
| JOHE KARL | Chief Scientific Officer | Sep 20, 2013 | Sale | $2.62 | 10,000 | 26,241 | 704,994 | Sep 23, 2013, 04:02 PM |
| JOHE KARL | Chief Scientific Officer | Sep 19, 2013 | Sale | $2.61 | 10,000 | 26,094 | 714,994 | Sep 19, 2013, 04:38 PM |
| JOHE KARL | Chief Scientific Officer | Aug 20, 2013 | Sale | $1.55 | 20,000 | 30,986 | 724,994 | Aug 21, 2013, 08:37 PM |
| JOHE KARL | Chief Scientific Officer | Jul 22, 2013 | Sale | $1.62 | 12,800 | 20,780 | 744,994 | Jul 22, 2013, 04:02 PM |
| JOHE KARL | Chief Scientific Officer | Jun 20, 2013 | Sale | $1.39 | 12,800 | 17,856 | 757,794 | Jun 21, 2013, 03:07 PM |
| GARR RICHARD | CEO | Jun 07, 2013 | Sale | $1.42 | 6,000 | 8,520 | 207,000 | Jun 11, 2013, 06:46 PM |
| JOHE KARL | Chief Scientific Officer | May 20, 2013 | Sale | $1.51 | 12,800 | 19,301 | 770,594 | May 21, 2013, 03:53 PM |
| JOHE KARL | Chief Scientific Officer | Apr 22, 2013 | Sale | $1.13 | 12,800 | 14,520 | 783,394 | Apr 23, 2013, 12:40 PM |
| JOHE KARL | Chief Scientific Officer | Mar 20, 2013 | Sale | $1.14 | 12,800 | 14,546 | 796,194 | Mar 22, 2013, 02:13 PM |
| GARR RICHARD | CEO | Feb 25, 2013 | Sale | $1.15 | 12,000 | 13,800 | 213,000 | Feb 26, 2013, 05:48 PM |
| JOHE KARL | Chief Scientific Officer | Feb 20, 2013 | Sale | $1.18 | 12,800 | 15,104 | 808,994 | Feb 21, 2013, 02:19 PM |
| JOHE KARL | Chief Scientific Officer | Jan 22, 2013 | Sale | $1.27 | 12,800 | 16,256 | 821,794 | Jan 23, 2013, 06:02 AM |
| JOHE KARL | Chief Scientific Officer | Dec 20, 2012 | Sale | $1.16 | 12,800 | 14,822 | 834,594 | Dec 26, 2012, 06:28 AM |
| JOHE KARL | Chief Scientific Officer | Nov 20, 2012 | Sale | $1.00 | 12,800 | 12,800 | 847,394 | Nov 27, 2012, 05:10 PM |
| OLDAKER WILLIAM CLYDE | Director | Sep 16, 2010 | Buy | $2.32 | 10,000 | 23,175 | 89,300 | Sep 20, 2010, 04:30 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Jones Mitchell Lawrence | CEO, CFO, Director | 05/06/2024 | 1,159 |
| Finley John David | CEO, CFO, Director | 05/06/2024 | 1,083 |
| Jones Mitchell Lawrence | Chief Medical Officer | 02/06/2024 | 939 |
| Finley John David | CEO, CFO, Director | 02/06/2024 | 4,692 |
| Finley John David | CEO, CFO, Director | 01/31/2024 | 5,590 |
| Williams Donald Allen | Director | 01/31/2024 | 6,050 |
| Finley John David | CEO, CFO, Director | 11/20/2023 | 5,100 |
| Jones Mitchell Lawrence | Chief Medical Officer | 11/07/2023 | 878 |
| Finley John David | CEO, CFO, Director | 10/04/2023 | 218 |
| Williams Donald Allen | Director | 09/27/2023 | 10,800 |
| Finley John David | CEO, CFO, Director | 09/27/2023 | 8,088 |
| Trenschel Robert J. | Director | 09/14/2023 | 192 |
| Finley John David | CEO, CFO, Director | 09/13/2023 | 9,825 |
| Finley John David | CEO, CFO, Director | 09/12/2023 | 1,174 |
| Finley John David | CEO, CFO, Director | 08/11/2023 | 728 |
| Finley John David | CEO, CFO, Director | 07/06/2023 | 686 |
| Finley John David | CEO, CFO, Director | 06/13/2023 | 1,619 |
| McRae Robert Curtis | Chief Operating Officer | 04/03/2023 | 540 |
| Finley John David | CEO, CFO, Director | 04/03/2023 | 874 |
| Finley John David | Chief Financial Officer | 09/01/2022 | 2,799 |
| Finley John David | Chief Financial Officer | 08/23/2022 | 1,176 |
| Hallam Thomas | Chief Executive Officer | 08/16/2022 | 10,000 |
| Finley John David | Chief Financial Officer | 08/16/2022 | 25,000 |
| Dawson Michael John | Chief Medical Officer | 03/29/2022 | 17,093 |
| Hallam Thomas | Chief Executive Officer | 03/28/2022 | 11,800 |
| Finley John David | Chief Financial Officer | 03/24/2022 | 8,174 |
| Finley John David | Chief Financial Officer | 09/21/2021 | 4,880 |
| Hallam Thomas | Chief Executive Officer | 09/21/2021 | 14,940 |
| Trenschel Robert J. | Director | 09/09/2021 | 9,826 |
| Trenschel Robert J. | Director | 09/08/2021 | 13,750 |
| Trenschel Robert J. | Director | 09/07/2021 | 7,525 |
| Trenschel Robert J. | Director | 08/31/2021 | 4,813 |
| Trenschel Robert J. | Director | 09/10/2021 | 6,383 |
| Finley John David | Chief Financial Officer | 08/27/2021 | 26,468 |
| Daly Richard J | Chief Executive Officer | 05/17/2017 | 30,000 |
| LLOYD JONES JONATHAN BRIAN | Chief Financial Officer | 03/24/2017 | 30,003 |
| Daly Richard J | Chief Executive Officer | 02/24/2017 | 10,001 |
| Daly Richard J | Chief Executive Officer | 01/25/2017 | 10,000 |
| Daly Richard J | Chief Executive Officer | 12/23/2016 | 10,000 |
| Daly Richard J | Chief Executive Officer | 11/25/2016 | 10,000 |
| Daly Richard J | Chief Executive Officer | 10/25/2016 | 10,000 |
| LLOYD JONES JONATHAN BRIAN | Chief Financial Officer | 09/23/2016 | 10,000 |
| Daly Richard J | Chief Executive Officer | 09/23/2016 | 10,000 |
| GARR RICHARD | CEO | 01/27/2016 | 4,332 |
| GARR RICHARD | CEO | 11/19/2015 | 43,065 |
| JOHE KARL | Chief Scientific Officer | 11/19/2015 | 44,663 |
| JOHE KARL | Chief Scientific Officer | 11/16/2015 | 27,250 |
| JOHE KARL | Chief Scientific Officer | 11/09/2015 | 29,500 |
| JOHE KARL | Chief Scientific Officer | 11/02/2015 | 29,355 |
| JOHE KARL | Chief Scientific Officer | 10/26/2015 | 28,190 |
| JOHE KARL | Chief Scientific Officer | 10/19/2015 | 30,690 |
| JOHE KARL | Chief Scientific Officer | 10/12/2015 | 32,725 |
| JOHE KARL | Chief Scientific Officer | 10/05/2015 | 31,460 |
| JOHE KARL | Chief Scientific Officer | 09/28/2015 | 41,000 |
| JOHE KARL | Chief Scientific Officer | 09/21/2015 | 38,078 |
| GARR RICHARD | CEO | 07/24/2015 | 733,908 |
| GARR RICHARD | CEO | 07/24/2015 | 400,000 |
| JOHE KARL | Chief Scientific Officer | 07/22/2015 | 1,018,466 |
| JOHE KARL | Chief Scientific Officer | 07/22/2015 | 600,000 |
| OLDAKER WILLIAM CLYDE | Director | 05/27/2015 | 79,200 |
| OLDAKER WILLIAM CLYDE | Director | 05/27/2015 | 79,200 |
| OGILVIE SCOTT VARDE | Director | 05/22/2015 | 79,201 |
| OGILVIE SCOTT VARDE | Director | 05/22/2015 | 79,200 |
| JOHE KARL | Chief Scientific Officer | 09/02/2014 | 24,540 |
| JOHE KARL | Chief Scientific Officer | 08/01/2014 | 16,680 |
| JOHE KARL | Chief Scientific Officer | 07/01/2014 | 25,020 |
| JOHE KARL | Chief Scientific Officer | 06/02/2014 | 25,500 |
| OLDAKER WILLIAM CLYDE | Director | 05/05/2014 | 3,448 |
| OLDAKER WILLIAM CLYDE | Director | 05/05/2014 | 49,874 |
| JOHE KARL | Chief Scientific Officer | 05/01/2014 | 63,765 |
| GARR RICHARD | CEO | 04/22/2014 | 29,750 |
| OLDAKER WILLIAM CLYDE | Director | 04/09/2014 | 45,999 |
| OLDAKER WILLIAM CLYDE | Director | 04/09/2014 | 66,000 |
| OGILVIE SCOTT VARDE | Director | 04/09/2014 | 66,000 |
| OGILVIE SCOTT VARDE | Director | 04/09/2014 | 66,000 |
| JOHE KARL | Chief Scientific Officer | 04/01/2014 | 24,638 |
| JOHE KARL | Chief Scientific Officer | 03/20/2014 | 24,249 |
| GARR RICHARD | CEO | 01/24/2014 | 626,210 |
| GARR RICHARD | CEO | 01/24/2014 | 200,000 |
| GARR RICHARD | CEO | 01/24/2014 | 199,999 |
| GARR RICHARD | CEO | 01/24/2014 | 200,000 |
| JOHE KARL | Chief Scientific Officer | 10/21/2013 | 23,458 |
| JOHE KARL | Chief Scientific Officer | 10/18/2013 | 24,446 |
| JOHE KARL | Chief Scientific Officer | 09/20/2013 | 26,241 |
| JOHE KARL | Chief Scientific Officer | 09/19/2013 | 26,094 |
| JOHE KARL | Chief Scientific Officer | 08/20/2013 | 30,986 |
| JOHE KARL | Chief Scientific Officer | 07/22/2013 | 20,780 |
| JOHE KARL | Chief Scientific Officer | 06/20/2013 | 17,856 |
| GARR RICHARD | CEO | 06/07/2013 | 8,520 |
| JOHE KARL | Chief Scientific Officer | 05/20/2013 | 19,301 |
| JOHE KARL | Chief Scientific Officer | 04/22/2013 | 14,520 |
| JOHE KARL | Chief Scientific Officer | 03/20/2013 | 14,546 |
| GARR RICHARD | CEO | 02/25/2013 | 13,800 |
| JOHE KARL | Chief Scientific Officer | 02/20/2013 | 15,104 |
| JOHE KARL | Chief Scientific Officer | 01/22/2013 | 16,256 |
| JOHE KARL | Chief Scientific Officer | 12/20/2012 | 14,822 |
| JOHE KARL | Chief Scientific Officer | 11/20/2012 | 12,800 |
| OLDAKER WILLIAM CLYDE | Director | 09/16/2010 | 23,175 |
Load More Insider Transactions
FUNDS WITH A POSITION IN PALISADE BIO INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 54,800 | 0.00005% | Exited | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 34,448 | 0% | No change | Other |
| BLACKROCK INC. | 9 | 0% | No change | Other |
CHANGE IN SHARES OUTSTANDING FOR PALISADE BIO INC
STOCK BUYBACKS FOR PALISADE BIO INC
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
-6.86%
1Q
06/30/2023
6.58%
2Q
BUYBACK ANNOUNCEMENT(S) FOR PALISADE BIO INC
LOADING...